Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Is government helping startups enough? Founders feel isolated, Kauffman survey finds
Early stage entrepreneurs struggle with the technical steps to getting started, a new Kauffman survey found, and founders don’t believe the government is helping them. The prevailing sentiment that entrepreneurs view themselves as isolated from assistance is understandable, said Melissa Roberts, vice president of strategy and economic development at the Enterprise Center in Johnson County.…
Kauffman survey: Women more critical of their own early-stage entrepreneurial efforts
Women entrepreneurs are more likely than their male counterparts to grade their performances harshly during the first year of business, though that tendency typically fades over time, according to a new survey by the Ewing Marion Kauffman Foundation. It often is about approaching the venture a realistic viewpoint, said Jeff Shackelford, executive director of Digital…
Video: ShotTracker fan app courts NAIA tourney crowds with AR experience
A new ShotTracker fan app — expected to launch today — will combine real-time analytics with augmented reality for a first-of-its-kind fan engagement opportunity at next week’s Division 1 NAIA basketball tournament, said co-founder Davyeon Ross. “We want to make the experience as great as possible for the end user,” Ross said, noting his company’s…
TechAccel, UC Davis lab developing wheat seed to combat climate change
A Kansas City-based tech and venture development firm hopes to engineer wheat seeds that produce higher yield by withstanding warmer temperatures. “We’re taking a concept that is pretty important for wheat worldwide,” said Brad Fabbri, Chief Science Officer of TechAccel. Increasing temperatures make growing wheat more difficult across the globe, studies show. Reports indicate climate…